Ascent Industries (ACNT) Q4 2024 earnings summary

Executive summary

• Achieved four consecutive quarters of adjusted EBITDA improvement and margin expansion, driven by cost management, operational efficiencies, and transformation initiatives, resulting in a debt-free balance sheet and strong liquidity.

• Generated $19.9 million year-over-year increase in adjusted EBITDA and nearly $15 million in free cash flow, ending 2024 with $16.1 million in cash.

• Transformation and recapitalization efforts established a stronger foundation for 2025, with a growing pipeline of opportunities and refreshed leadership.

Financial highlights

• Q4 net sales were $40.7 million, down 1.3% year-over-year; full-year net sales were $177.9 million, down 7.9%.

• Q4 gross profit increased to $7.3 million (17.9% margin) from a $2.1 million loss; full-year gross profit rose to $22.1 million (12.4% margin) from $1.5 million.

• Q4 net income from continuing operations was $0.1 million ($0.01/share) versus a $7.5 million loss ($0.73/share) in Q4 2023; full-year net loss narrowed to $11.2 million ($1.11/share) from $34.2 million ($3.37/share).

• Adjusted EBITDA for Q4 was $2.6 million (6.3% margin) versus negative $5.9 million (-14.4% margin); full-year adjusted EBITDA was $4 million (2.3% margin) versus negative $15.9 million (-8.2%).

• Recorded a $6.2 million non-cash, one-time tax charge in 2024 related to a valuation allowance against deferred tax assets.

Outlook and guidance

• Entering 2025 with positive momentum, expecting more favorable post-election market dynamics and top-line growth in the second half of 2025.

• Focused on sustaining or improving gross profit and margin profile through cost and product mix optimization.

• Ongoing focus on organic growth in Specialty Chemicals and selective M&A.